AAAEX — AllianzGI Health Sciences Fund
Data updated: 2026-09-11
AAAEX — AllianzGI Health Sciences Fund. United States Large Cap Blend / Core Health Care Equity · $91.70M AUM. Holdings, fees, performance and SEC filings.
AAAEX Fund Overview
AAAEX — AllianzGI Health Sciences Fund is a US mutual fund managed by Virtus Investment Trust, categorised as United States Large Cap Blend / Core Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Virtus Investment Trust
- Category: United States Large Cap Blend / Core Health Care Equity
- Assets under management: $91.70M
- 1-year return: 4.7%
- Ticker: AAAEX
- SEC CIK: 0000867297
- SEC series ID: S000007977
- Share class ID: C000220799
AAAEX Investment Objective and Strategy
AllianzGI Health Sciences Fund describes its objective and strategy as follows, from its latest prospectus filed with the SEC by Virtus Investment Trust.
Investment objective
The Fund seeks long-term capital appreciation.
Principal investment strategy
The Fund seeks to achieve its objective by normally investing at least 80% of its net assets (plus borrowings made for investment purposes) in health sciences-related companies. The Fund considers health sciences-related companies to include companies that design, manufacture or sell products or services used for or in connection with healthcare, medicine or life sciences. The Fund will invest primarily in common stocks and other equity securities. Although the Fund may invest in companies of any market capitalization, the Fund does not currently intend to invest more than 15% of its assets in companies with market capitalizations below $1 billion. The Fund may invest in U.S. and non-U.S. companies, and currently expects the majority of its non-U.S. investments will normally be in Asia and Western Europe.
The Fund may invest up to 15% of its assets in emerging market securities (but no more than 10% in any one emerging market country). In analyzing specific companies for possible investment, the portfolio managers ordinarily look for the following characteristics: higher than average growth and strong potential for capital appreciation; substantial capacity for growth in revenue through either an expanding market or market share; a strong balance sheet; superior management; strong commitment to research and product development; and differentiated or superior products and services or a steady stream of new products and services. In addition to common stocks and other equity securities (such as preferred stocks, convertible securities and warrants), the Fund may invest in securities issued in initial public offerings (IPOs), and may utilize foreign currency exchange contracts, options, stock index futures contracts, short sales and other derivative instruments.
Although the Fund did not invest significantly in derivative instruments as of the most recent fiscal year end, it may do so at any time. While the Fund may invest in derivatives of any kind, it expects to purchase put and call options on securities for hedging, risk management or other purposes.
AAAEX Holdings
Top 10 holdings of AllianzGI Health Sciences Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Eli Lilly & Company | 14.84% |
| West Pharmaceutical Services, Inc. | 5.92% |
| Abbvie, Inc. | 5.52% |
| Vertex Pharmaceuticals, Inc. | 5.32% |
| Merck & Company, Inc. | 5.06% |
| Unitedhealth Group, Inc. | 4.65% |
| Mckesson Corp. | 4.57% |
| Mettler-Toledo International, Inc. | 3.99% |
| Intuitive Surgical, Inc. | 3.89% |
| Amgen, Inc. | 3.85% |
AAAEX Portfolio Allocation
Asset-class allocation of AllianzGI Health Sciences Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 98.5% |
AAAEX Performance
Total returns for AAAEX (as of 2026-10-01), from SEC filings.
| Period | Total return |
|---|---|
| 1 year | 4.7% |
| 3 years (annualised) | 3.1% |
AAAEX Risk Information
Risk metrics for AAAEX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 17.9%
AAAEX Costs and Fees
AAAEX costs about $103 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.03%
- Gross expense ratio: 1.03%
- Portfolio turnover: 8%
- Brokerage commissions: 1.20 bps of average net assets (SEC N-CEN)
AAAEX Cashflows
Over the 12 months to 2026-06, AllianzGI Health Sciences Fund had net outflows of $20.71M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-06 | −$1.47M |
| 2026-05 | −$921.10K |
| 2026-04 | −$1.45M |
| 2026-03 | −$1.67M |
| 2026-02 | −$1.51M |
| 2026-01 | −$1.56M |
AAAEX Debt Constituents
No individual debt constituents are reported in AllianzGI Health Sciences Fund's latest SEC N-PORT filing.
AAAEX Prospectus and SEC Filings
Official AllianzGI Health Sciences Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2025-10-22
- Prospectus (485BPOS) — filed 2024-10-24
- Prospectus supplement (497) — filed 2024-03-25
- Portfolio holdings (N-PORT) — filed 2026-08-28
- Portfolio holdings (N-PORT) — filed 2026-05-29
- Portfolio holdings (N-PORT) — filed 2026-02-26
- Annual census (N-CEN) — filed 2026-09-11
- Annual census (N-CEN) — filed 2025-09-12
Related Funds
Other United States Large Cap Blend / Core Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.